TrianglePUBLICATIONS · 27837256
Pharmacokinetics, immunogenicity, and safety of weekly dosing of brentuximab vedotin in pediatric patients with Hodgkin lymphoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer Chemother Pharmacol
- Publication date
- 2016 Dec
- First author
- Flerlage JE
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Flerlage JE
- type
- Author
- name
- Metzger ML
- type
- Author
- name
- Wu J
- type
- Author
- name
- Panetta JC
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Flerlage JE
- type
- Author
- name
- Metzger ML
- type
- Author
- name
- Wu J
- type
- Author
- name
- Panetta JC
- type
- Author
- bibliography ids
- nci-bib-0771da7d805e96a154ca55af
- book metadata
- content sha256
- 9a3a79afd17f84718360eb3cb6808a763f4f5cf918ed05100c88a2fc47030a1c
- document type
- citation
- dois
- 10.1007/s00280-016-3180-x
- electronic publication date
- display
- 2016 Nov 11
- precision
- day
- year
- 2016
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:27837256
- immutable id
- pubmed:27837256@9a3a79afd17f84718360eb3cb6808a763f4f5cf918ed05100c88a2fc47030a1c
- journal
- abbreviation
- Cancer Chemother Pharmacol
- issn electronic
- 1432-0843
- issn print
- 0344-5704
- issue
- 6
- name
- Cancer chemotherapy and pharmacology
- nlm unique id
- 7806519
- pages
- 1217-1223
- volume
- 78
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 27837256
- provenance
- batch id
- d649bcb2d98dbbacd53c
- provider
- NCBI PubMed ESummary
- record sha256
- 375dc59a0c6f18da8d0bd1f823fcfa8542b8d44f1c89d0c225ac8ce6c1252173
- response sha256
- 26648a40f123f366675007f51cc29befd1f9a89273ca2da87c477c54d2d15d20
- retrieved at
- 2026-09-09T23:47:20.761544+00:00
- publication date
- display
- 2016 Dec
- precision
- month
- year
- 2016
- publication types
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Pharmacokinetics, immunogenicity, and safety of weekly dosing of brentuximab vedotin in pediatric patients with Hodgkin lymphoma.
Preserved source evidence · Not medical advice